+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Acute Myeloid Leukemia Market and Competitive Landscape - 2020

  • ID: 5023589
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Acute Myeloid Leukemia Market and Competitive Landscape - 2020, provides comprehensive insights into the Acute Myeloid Leukemia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Acute Myeloid Leukemia market size and drug sales. It also provides insights into Acute Myeloid Leukemia epidemiology and late stage pipeline.

This research covers the following: Acute Myeloid Leukemia treatment options, Acute Myeloid Leukemia late stage clinical trials pipeline, Acute Myeloid Leukemia prevalence by countries, Acute Myeloid Leukemia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Acute Myeloid Leukemia pipeline: Find out drugs in clinical trials for the treatment of Acute Myeloid Leukemia by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Acute Myeloid Leukemia epidemiology: Find out the number of patients diagnosed (prevalence) with Acute Myeloid Leukemia by countries
  • Acute Myeloid Leukemia drugs: Identify key drugs marketed and prescribed for Acute Myeloid Leukemia in the US, including trade name, molecule name, and company
  • Acute Myeloid Leukemia drugs sales: Find out the sales value for Acute Myeloid Leukemia drugs by countries
  • Acute Myeloid Leukemia market valuations: Find out the market size for Acute Myeloid Leukemia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Acute Myeloid Leukemia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Acute Myeloid Leukemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Acute Myeloid Leukemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze Acute Myeloid Leukemia drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Acute Myeloid Leukemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Acute Myeloid Leukemia Treatment Options

2. Acute Myeloid Leukemia Pipeline Insights
2.1. Acute Myeloid Leukemia Phase 3 Clinical Trials
2.2. Acute Myeloid Leukemia Phase 2 Clinical Trials
2.3. Acute Myeloid Leukemia Phase 1 Clinical Trials

3. Acute Myeloid Leukemia Epidemiology Analysis by Countries

4. Germany Acute Myeloid Leukemia Market Insights
4.1. Marketed Drugs for Acute Myeloid Leukemia in Germany
4.2. Germany Acute Myeloid Leukemia Market Size & Forecast
4.3. Germany Acute Myeloid Leukemia Drugs Sales Forecast
4.4. Germany Acute Myeloid Leukemia Market Share Analysis

5. France Acute Myeloid Leukemia Market Insights
5.1. Marketed Drugs for Acute Myeloid Leukemia in France
5.2. France Acute Myeloid Leukemia Market Size & Forecast
5.3. France Acute Myeloid Leukemia Product Sales Forecast
5.4. France Acute Myeloid Leukemia Market Share Analysis

6. Italy Acute Myeloid Leukemia Market Insights
6.1. Marketed Drugs for Acute Myeloid Leukemia in Italy
6.2. Italy Acute Myeloid Leukemia Market Size & Forecast
6.3. Italy Acute Myeloid Leukemia Product Sales Forecast
6.4. Italy Acute Myeloid Leukemia Market Share Analysis

7. Spain Acute Myeloid Leukemia Market Insights
7.1. Marketed Drugs for Acute Myeloid Leukemia in Spain
7.2. Spain Acute Myeloid Leukemia Market Size & Forecast
7.3. Spain Acute Myeloid Leukemia Product Sales Forecast
7.4. Spain Acute Myeloid Leukemia Market Share Analysis

8. UK Acute Myeloid Leukemia Market Insights
8.1. Marketed Drugs for Acute Myeloid Leukemia in UK
8.2. UK Acute Myeloid Leukemia Market Size & Forecast
8.3. UK Acute Myeloid Leukemia Product Sales Forecast
8.4. UK Acute Myeloid Leukemia Market Share Analysis

9. Europe Acute Myeloid Leukemia Market Insights
9.1. Europe Acute Myeloid Leukemia Market Size & Forecast
9.2. Europe Acute Myeloid Leukemia Product Sales Forecast
9.3. Europe Acute Myeloid Leukemia Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Acute Myeloid Leukemia Phase 3 Clinical Trials, Global, 2020
Table 2: Acute Myeloid Leukemia Phase 2 Clinical Trials, Global, 2020
Table 3: Acute Myeloid Leukemia Phase 1 Clinical Trials, Global, 2020
Table 4: Acute Myeloid Leukemia Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Acute Myeloid Leukemia in Germany, 2019
Table 6: Germany Acute Myeloid Leukemia Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Table 8: Germany Acute Myeloid Leukemia Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Acute Myeloid Leukemia in France, 2019
Table 10: France Acute Myeloid Leukemia Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Table 12: France Acute Myeloid Leukemia Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Acute Myeloid Leukemia in Italy, 2019
Table 14: Italy Acute Myeloid Leukemia Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Table 16: Italy Acute Myeloid Leukemia Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Acute Myeloid Leukemia in Spain, 2019
Table 18: Spain Acute Myeloid Leukemia Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Table 20: Spain Acute Myeloid Leukemia Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Acute Myeloid Leukemia in UK, 2019
Table 22: UK Acute Myeloid Leukemia Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Table 24: UK Acute Myeloid Leukemia Market Events and Trends, 2016 - 2024
Table 25: Europe Acute Myeloid Leukemia Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Acute Myeloid Leukemia Pipeline by Phase (%), Global, 2020
Figure 2: Acute Myeloid Leukemia Prevalence by Countries, 2016 - 2024
Figure 3: Germany Acute Myeloid Leukemia Market Size ($mn), 2016 - 2024
Figure 4: Germany Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Figure 5: Germany Acute Myeloid Leukemia Market Share by Drugs (%), 2019
Figure 6: Germany Acute Myeloid Leukemia Market - Future Market Share (%), 2024
Figure 7: France Acute Myeloid Leukemia Market Size ($mn), 2016 - 2024
Figure 8: France Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Figure 9: France Acute Myeloid Leukemia Market Share by Drugs (%), 2019
Figure 10: France Acute Myeloid Leukemia Market - Future Market Share (%), 2024
Figure 11: Italy Acute Myeloid Leukemia Market Size ($mn), 2016 - 2024
Figure 12: Italy Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Figure 13: Italy Acute Myeloid Leukemia Market Share by Drugs (%), 2019
Figure 14: Italy Acute Myeloid Leukemia Market - Future Market Share (%), 2024
Figure 15: Spain Acute Myeloid Leukemia Market Size ($mn), 2016 - 2024
Figure 16: Spain Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Figure 17: Spain Acute Myeloid Leukemia Market Share by Drugs (%), 2019
Figure 18: Spain Acute Myeloid Leukemia Market - Future Market Share (%), 2024
Figure 19: UK Acute Myeloid Leukemia Market Size ($mn), 2016 - 2024
Figure 20: UK Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Figure 21: UK Acute Myeloid Leukemia Market Share by Drugs (%), 2019
Figure 22: UK Acute Myeloid Leukemia Market - Future Market Share (%), 2024
Figure 23: Europe Acute Myeloid Leukemia Market Size ($mn), 2016 - 2024
Figure 24: Europe Acute Myeloid Leukemia Product Sales ($mn), 2016 - 2024
Figure 25: Europe Acute Myeloid Leukemia Market Share by Drugs (%), 2019
Figure 26: Europe Acute Myeloid Leukemia Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll